tiprankstipranks
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
Holding RNAC?
Track your performance easily

Cartesian Therapeutics (RNAC) Financial Statements

1,100 Followers

Cartesian Therapeutics Financial Overview

Cartesian Therapeutics's market cap is currently ―. The company's EPS TTM is $-52.639; its P/E ratio is -0.36; Cartesian Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.80. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 250.00K$ 33.45M$ 5.84M$ 8.27M$ 6.55M
Gross Profit$ 250.00K$ 33.45M$ 5.84M$ 8.27M$ 6.55M
EBIT$ -24.18M$ 13.84M$ -17.52M$ -196.66M$ -7.73M
EBITDA$ -23.24M$ 14.63M$ -16.83M$ -196.39M$ -7.54M
Net Income Common Stockholders$ -24.18M$ 9.63M$ -56.82M$ -177.66M$ -9.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 219.20M$ 87.23M$ 103.42M$ 76.91M$ 79.60M
Total Assets$ 455.32M$ 347.74M$ 325.21M$ 305.05M$ 106.03M
Total Debt$ 14.65M$ 14.87M$ 10.46M$ 10.96M$ 10.48M
Net Debt$ -204.55M$ -72.36M$ -92.96M$ -65.96M$ -69.12M
Total Liabilities$ 454.56M$ 449.20M$ 442.01M$ 444.68M$ 45.70M
Stockholders Equity$ 752.00K$ -101.46M$ -116.80M$ -440.18M$ 60.33M
Cash Flow-
Free Cash Flow$ 7.49M$ -16.03M$ -16.52M$ -23.35M$ -9.21M
Operating Cash Flow$ 13.69M$ -14.45M$ -15.92M$ -23.29M$ -9.21M
Investing Cash Flow$ -6.20M$ -1.59M$ -602.00K$ 6.50M-
Financing Cash Flow$ 124.49M$ 120.00K$ 43.03M$ 14.08M$ -24.79M
Currency in USD

Cartesian Therapeutics Earnings and Revenue History

Cartesian Therapeutics Debt to Assets

Cartesian Therapeutics Cash Flow

Cartesian Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis